Effect of osteopontin on TIMP-1 and TIMP-2 mRNA in chondrocytes of human knee osteoarthritis in vitro

Experimental and Therapeutic Medicine

Volumn 8, Issue 2, 2014, Pages 391-394

  Zhang, Fang Jie ^a   Yu, Wen Bo ^a,b   Luo, Wei ^a   Gao, Shu Guang ^a,c   Li, Yu Sheng ^a   Lei, Guang Hua ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Department of Orthopaedics The First People's Hospital of Nanpin   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Chondrocytes; Osteoarthritis; Osteopontin; Tissue inhibitors of metalloproteinase 1; Tissue inhibitors of metalloproteinase 2

Indexed keywords

MESSENGER RNA; OSTEOPONTIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KNEE OSTEOARTHRITIS; MTT ASSAY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; TOTAL KNEE REPLACEMENT;

EID: 84902587289     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1750     Document Type: Article

References (19)

1. Roughley PJ: Articular cartilage and changes in arthritis: noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage. Arthritis Res 3: 342-347, 2001.
2. Eyre D: Collagen of articular cartilage. Arthritis Res 4: 30-35, 2002.
3. Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, Donell ST and Clark IM: Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 8: R124, 2006.
4. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS and Woessner JF Jr: Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84: 678-685, 1989.
5. Hughes CE, Little CB, Büttner FH, Bartnik E and Caterson B: Differential expression of aggrecanase and matrix metalloproteinase activity in chondrocytes isolated from bovine and porcine articular cartilage. J Biol Chem 273: 30576-30582, 1998.
6. Pullig O, Weseloh G, Gauer S and Swoboda B: Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol 19: 245-255, 2000.
7. McKee MD, Glimcher MJ and Nanci A: High-resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia. Anat Rec 234: 479-492, 1992.
8. Honsawek S, Tanavalee A, Sakdinakiattikoon M, Chayanupatkul M and Yuktanandana P: Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem 42: 808-812, 2009.
9. Gao SG, Li KH, Zeng KB, Tu M, Xu M and Lei GH: Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthritis Cartilage 18: 82-87, 2010.
10. Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT and Amin AR: Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum 44: 578-584, 2001.
11. Matsui Y, Iwasaki N, Kon S, Takahashi D, Morimoto J, Matsui Y, Denhardt DT, Rittling S, Minami A and Uede T: Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthritis Rheum 60: 2362-2371, 2009.
12. Pelletier JP, Mineau F, Faure MP and Martel-Pelletier J: Imbalance between the mechanisms of activation and inhibition of metalloproteases in early lesions of experimental osteoarthritis. Arthritis Rheum 33: 1466-1476, 1990.
13. Knäuper V, López-Otin C, Smith B, Knight G and Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 271: 1544-1550, 1996.
14. Tetlow LC, Adlam DJ and Woolley DE: Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 44: 585-594, 2001.
15. Dean DD and Woessner JF Jr: Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases. Biochem J 218: 277-280, 1984.
16. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S and He CS: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 86: 8207-8211, 1989.
17. Chevalier X, Conrozier T, Gehrmann M, Claudepierre P, Mathieu P, Unger S and Vignon E: Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritis. Osteoarthritis Cartilage 9: 300-307, 2001.
18. Petrow PK, Hummel KM, Schedel J, Franz JK, Klein CL, Müller-Ladner U, Kriegsmann J, Chang PL, Prince CW, Gay RE and Gay S: Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum 43: 1597-1605, 2000.
19. Ohshima S, Kobayashi H, Yamaguchi N, Nishioka K, Umeshita-Sasai M, Mima T, Nomura S, Kon S, Inobe M, Uede T and Saeki Y: Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis. Arthritis Rheum 46: 1094-1101, 2002.